RejuvaKnee™

About Regenity Biosciences

Regenity Biosciences is a private, commercial-stage medical technology company focused on regenerative medicine and cell therapy. It has successfully commercialized its first product, RejuvaKnee™, and maintains a robust CDM services business built on expertise in collagen, bioceramics, and synthetic polymers. The company is backed by private equity investors Cinven and Linden Capital Partners and has a global commercial footprint with regulatory approvals in 86 countries. Its strategy combines proprietary product development with a high-value services model for other medtech innovators.

Therapeutic Areas